Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist
Author:
Affiliation:
1. USA Elixiria Biotech Inc, Hartsdale, NY, USA
2. Shanghai Elixiria Biotech Co., Ltd., Shanghai, China
3. Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Funder
NIH NIDCR
Publisher
SAGE Publications
Subject
Anesthesiology and Pain Medicine,Cellular and Molecular Neuroscience,Molecular Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1744806919884498
Reference15 articles.
1. Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury
2. Experimental Drugs for Neuropathic Pain
3. Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms
4. Pathological pain and the neuroimmune interface
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease;Neurobiology of Disease;2024-10
2. Preclinical orofacial pain assays and measures and chronic primary orofacial pain research: where we are and where we need to go;Frontiers in Pain Research;2023-05-24
3. Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress;Neuropharmacology;2022-11
4. Polarization of Microglia and Its Therapeutic Potential in Sepsis;International Journal of Molecular Sciences;2022-04-28
5. Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications;Expert Review of Clinical Pharmacology;2022-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3